This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
Dr. Padmanee Sharma of MD Anderson discusses what breakthroughs and advances might lie ahead for the field of cancer immunotherapy in 2020.
On February 4, join the global awareness campaign to support cancer prevention and lifesaving treatments.
CRI’s Vanessa Lucey, Ph.D., MBA, speaks on the "Landscape and Evolution of the Marketplace" panel on February 27, 2020.
CRI's Vanessa Lucey, Ph.D., MBA, is presenting at the MDICT task force meeting on March 1, 2020 at 6:00 p.m.
Free event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy in Seattle.
The Cancer Research Institute assembles a team to run and raise critical funds for highly promising cancer immunotherapy research.
Discover antibody-based imaging strategies that help doctors visualize patients’ tumors and immune cells in real-time via PET scans.
CRI's Vanessa Lucey, Ph.D., MBA, speaks on the "Innovating Finance, Non-Traditional Funding Sources" panel.
Free event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy in Buffalo.
Guests are invited to walk “through” the kitchen at The Pool & The Grill restaurants in the Seagram Building on Sunday, April 26.
CRI's Vanessa Lucey, Ph.D., MBA, speaks on the "Investing into Oncology: Who, What and Where?" panel on May 6, 2020.
Join us for the 8th Annual Cancer Immunotherapy Month™ in June hosted by the Cancer Research Institute.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
How the video game live stream fundraiser “Prepare to Destroy Cancer” is supporting cancer immunotherapy research
How the microbiome influences the fight against cancer and what Dr. Sonnenberg hopes to accomplish during the next five years as a CRI Lloyd J. Old STAR.